miR-181a is a negative regulator of GRIA2 in methamphetamine-use disorder

A previous study reported that the miR-181a level in serum was significantly different between patients with methamphetamine-use disorder and healthy controls and that chronic methamphetamine use down-regulates the expression of miR-181a. Bioinformatic analysis predicted that miR-181a might bind the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kai, Wang, Qingzhong, Jing, Xuxiu, Zhao, Yan, Jiang, Haifeng, Du, Jiang, Yu, Shunying, Zhao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073328/
https://www.ncbi.nlm.nih.gov/pubmed/27767084
http://dx.doi.org/10.1038/srep35691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073328/
https://www.ncbi.nlm.nih.gov/pubmed/27767084
http://dx.doi.org/10.1038/srep35691

Ejemplares similares